Long-term safety, efficacy, and quality of life in patients with juvenile idiopathic arthritis treated with intravenous abatacept for up to seven years
Identifiers
Identifiers
Services
Services
Date issued
2015Journal title
Arthritis and Rheumatology
Type of content
Artigo
